Lyell Immunopharma Inc (LYEL) Stock Price, Quote, News & History

LYELNASDAQ
$12.40
0.433.59%
Last update: Jun 8, 9:37 AM

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-133.80M
Investing Cash Flow (TTM)
2.01M
Financing Cash Flow (TTM)
102.13M
Free Cash Flow (TTM)
-134.42M
Capital Expenditure (TTM)
-623.00K
Net Change in Cash (TTM)
-29.66M

Analyst Trends and Forecast

1
Dec 25
0
0
0
0
Mar
1
Apr
1
May
1
Jun
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
3.3
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$185.64M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
7269.25
PB Ratio (TTM)
1.02
Earnings Yield % (TTM)
-114.07%
Earnings Yield % (FWD)
-59.63%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$11.73

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$90.77M
Debt to Equity
0.14
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$12.20
Close
-
Volume / Avg.
6.45K / 92.66K
Day Range
$11.90 - $12.47
52 Wk Range
8.46 - 45.00
Market Cap
$289.34M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
26
Short Interest
6.76%
Days to Cover
23.25

About

Sector
Health Care
Industry
Biotechnology
Lyell Immunopharma Inc s a late-stage clinical cell therapy company advancing a pipeline of proprietary next-generation autologous chimeric antigen receptor (CAR) T-cell product candidates for patients with hematologic malignancies and solid tumors. ...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Lyell Immunopharma (LYEL) stock?

A

You can purchase shares of Lyell Immunopharma (NASDAQ:LYEL) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Lyell Immunopharma (LYEL) competitors?

A

There are no as such competitors for Lyell Immunopharma.

Q

What is the forecast, or price target, for Lyell Immunopharma (LYEL) stock?

A

Lyell Immunopharma has a consensus price target of $22.71.

Q

What is the current price for Lyell Immunopharma (LYEL)?

A

The stock price for Lyell Immunopharma (NASDAQ: LYEL) is $12.4 last updated June 8, 2026 at 9:37 AM EDT.

Q

Does Lyell Immunopharma (LYEL) pay a dividend?

A

There are no upcoming dividends for Lyell Immunopharma.

Q

When is Lyell Immunopharma (NASDAQ:LYEL) reporting earnings?

A

Lyell Immunopharma does not have any upcoming earnings scheduled.

Q

Is Lyell Immunopharma (LYEL) going to split?

A

There is no upcoming split for Lyell Immunopharma.

Q

What sector and industry does Lyell Immunopharma (LYEL) operate in?

A

Lyell Immunopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.